Skip to main content
Premium Trial:

Request an Annual Quote

IntegenX Names First Partner for RapidHit 200 Early Access Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IntegenX today announced the launch of its Early Access Program for the RapidHit 200 Human Identification System and the signing of Key Forensic Sciences as the first international partner of the program.

The new program provides IntegenX's partners with advanced product access and training, and partners will receive pre-production prototypes of the RapidHit 200 instrument, disposable reagent cartridges, and application priority in the US and abroad, the Pleasanton, Calif.-based company said.

As the first partner in the Early Access Program, Key Forensic Sciences will be able to optimize and use the RapidHit 200 instrument for commercial forensic services in the UK, where it is based. Objectives of the partnership include validation of the system and introduction of fast human ID services to police forces in the UK and Wales.

RapidHit 200 automates and accelerates production of standardized DNA profiles from mouth swabs and other human tissue samples.

Terms of the deal were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.